The DOI matches its Crossref record; 180 of the 180 references it cites were found in a registry or an index.
Interferons and viruses: an evolutionary arms race of molecular interactions
Open accessAbstract
Over half a century has passed since interferons (IFNs) were discovered and shown to inhibit virus infection in cultured cells. Since then, researchers have steadily brought to light the molecular details of IFN signaling, catalogued their pleiotropic effects on cells, and harnessed their therapeutic potential for a variety of maladies. While advances have been plentiful, several fundamental questions have yet to be answered and much complexity remains to be unraveled. We explore the current knowledge surrounding four main questions: are type I IFN subtypes differentially produced in response to distinct pathogens? How are IFN subtypes distinguished by cells? What are the mechanisms and consequences of viral antagonism? Lastly, how can the IFN response be harnessed to improve vaccine efficacy?
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pushko, P., Pumpens, P., & Grens, E. (2013) · Intervirology · doi:10.1159/000346773 · Cited by 5,950
Cyclic GMP-AMP Synthase Is a Cytosolic DNA Sensor That Activates the Type I Interferon Pathway
Sun, L., Wu, J., Du, F., Chen, X., & Chen, Z. J. (2013) · Science · doi:10.1126/science.1232458 · Cited by 4,996
Interferon-γ: an overview of signals, mechanisms and functions
Schroder, K., Hertzog, P. J., Ravasi, T., & Hume, D. A. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.0603252 · Cited by 4,120
CpG motifs in bacterial DNA trigger direct B-cell activation
Krieg, A. M., Yi, A.-K., Matson, S., Waldschmidt, T. J., Bishop, G. A., Teasdale, R., Koretzky, G. A., & Klinman, D. M. (1995) · Nature · doi:10.1038/374546a0 · Cited by 3,508
STATs: transcriptional control and biological impact
Levy, D. E., & Darnell, J. E. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm909 · Cited by 3,201
Interferon-stimulated genes: A complex web of host defenses
Schneider, W. M., Chevillotte, M. D., & Rice, C. M. (2014) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032713-120231 · Cited by 3,067
Self-citation5'-Triphosphate RNA Is the Ligand for RIG-I
Hornung, V., Ellegast, J., Kim, S., Brzózka, K., Jung, A., Kato, H., Poeck, H., Akira, S., Conzelmann, K.-K., Schlee, M., et al. (2006) · Science · doi:10.1126/science.1132505 · Cited by 2,474
A diverse range of gene products are effectors of the type I interferon antiviral response
Schoggins, J. W., Wilson, S. J., Panis, M., Murphy, M. Y., Jones, C. T., Bieniasz, P., & Rice, C. M. (2011) · Nature · doi:10.1038/nature09907 · Cited by 2,433
Self-citationCardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus
Meylan, E., Curran, J., Hofmann, K., Moradpour, D., Binder, M., Bartenschlager, R., & Tschopp, J. (2005) · Nature · doi:10.1038/nature04193 · Cited by 2,401
The Nature of the Principal Type 1 Interferon-Producing Cells in Human Blood
Siegal, F. P., Kadowaki, N., Shodell, M., Fitzgerald-Bocarsly, P. A., Shah, K., Ho, S., Antonenko, S., & Liu, Y.-J. (1999) · Science · doi:10.1126/science.284.5421.1835 · Cited by 2,293
The STATs of cancer — new molecular targets come of age
Yu, H., & Jove, R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1275 · Cited by 2,278
RIG-I-mediated antiviral responses to single-stranded RNA bearing 5’-phosphates
Pichlmair, A., Schulz, O., Tan, C. P., Näslund, T. I., Liljeström, P., Weber, F., & Reis e Sousa, C. (2006) · Science · doi:10.1126/science.1132998 · Cited by 2,210
Zhong, Z., Wen, Z., & Darnell, J. E. (1994) · Science · doi:10.1126/science.8140422 · Cited by 2,070
Wen, Z., Zhong, Z., & Darnell, J. E. (1995) · Cell · doi:10.1016/0092-8674(95)90311-9 · Cited by 1,974
IFN-λs mediate antiviral protection through a distinct class II cytokine receptor complex
Kotenko, S. V., Gallagher, G., Baurin, V. V., Lewis-Antes, A., Shen, M., Shah, N. K., Langer, J. A., Sheikh, F., Dickensheets, H., & Donnelly, R. P. (2003) · Nature Immunology · doi:10.1038/ni875 · Cited by 1,868
Interferons, interferon‐like cytokines, and their receptors
Pestka, S., Krause, C. D., & Walter, M. R. (2004) · Immunological Reviews · doi:10.1111/j.0105-2896.2004.00204.x · Cited by 1,766
The history of toll-like receptors - redefining innate immunity
O'Neill, L. A. J., Golenbock, D., & Bowie, A. G. (2013) · Nature reviews. Immunology · doi:10.1038/nri3446 · Cited by 1,765
CGAS produces a 2′-5′-linked cyclic dinucleotide second messenger that activates STING.
Ablasser, A., Goldeck, M., Cavlar, T., Deimling, T., Witte, G., Röhl, I., Hopfner, K.-P., Ludwig, J., & Hornung, V. (2013) · Nature · doi:10.1038/nature12306 · Cited by 1,695
TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity
Gack, M. U., Shin, Y. C., Joo, C.-H., Urano, T., Liang, C., Sun, L., Takeuchi, O., Akira, S., Chen, Z., Inoue, S., et al. (2007) · Nature · doi:10.1038/nature05732 · Cited by 1,695
Plasmacytoid dendritic cells in immunity
Colonna, M., Trinchieri, G., & Liu, Y.-J. (2004) · Nature Immunology · doi:10.1038/ni1141 · Cited by 1,678
Kato, H., Takeuchi, O., Mikamo-Satoh, E., Hirai, R., Kawai, T., Matsushita, K., Hiiragi, A., Dermody, T. S., Fujita, T., & Akira, S. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20080091 · Cited by 1,599
IL-28, IL-29 and their class II cytokine receptor IL-28R
Sheppard, P., Kindsvogel, W., Xu, W., Henderson, K., Schlutsmeyer, S., Whitmore, T. E., Kuestner, R., Garrigues, U., Birks, C., Roraback, J., et al. (2003) · Nature Immunology · doi:10.1038/ni873 · Cited by 1,570
A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A
Yang, X.-J., Ogryzko, V. V., Nishikawa, J.-I., Howard, B. H., & Nakatani, Y. (1996) · Nature · doi:10.1038/382319a0 · Cited by 1,479
Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8)
Russo, J. J., Bohenzky, R. A., Chien, M.-C., Chen, J., Yan, M., Maddalena, D., Parry, J. P., Peruzzi, D., Edelman, I. S., Chang, Y., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.25.14862 · Cited by 1,467
Nipah Virus: A Recently Emergent Deadly Paramyxovirus
Chua, K. B., Bellini, W. J., Rota, P. A., Harcourt, B. H., Tamin, A., Lam, S. K., Ksiazek, T. G., Rollin, P. E., Zaki, S. R., Shieh, W.-J., et al. (2000) · Science · doi:10.1126/science.288.5470.1432 · Cited by 1,395
Hou, F., Sun, L., Zheng, H., Skaug, B., Jiang, Q.-X., & Chen, Z. J. (2011) · Cell · doi:10.1016/j.cell.2011.06.041 · Cited by 1,282
Innate Immune Sensing and Signaling of Cytosolic Nucleic Acids
Wu, J., & Chen, Z. J. (2014) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032713-120156 · Cited by 1,183
Evolution of the mutation rate
Lynch, M. (2010) · Trends in Genetics · doi:10.1016/j.tig.2010.05.003 · Cited by 1,151
The multifunctional NS1 protein of influenza A viruses
Hale, B. G., Randall, R. E., Ortín, J., & Jackson, D. (2008) · Journal of General Virology · doi:10.1099/vir.0.2008/004606-0 · Cited by 1,079
Marie, I. (1998) · The EMBO Journal · doi:10.1093/emboj/17.22.6660 · Cited by 1,049
Buettner, R., Mora, L. B., & Jove, R. (2002) · PubMed · Cited by 1,040
Enhanced DNA-Binding Activity of a Stat3-Related Protein in Cells Transformed by the Src Oncoprotein
Yu, C.-L., Meyer, D. J., Campbell, G. S., Larner, A. C., Carter-Su, C., Schwartz, J., & Jove, R. (1995) · Science · doi:10.1126/science.7541555 · Cited by 931
Prokunina-Olsson, L., Muchmore, B., Tang, W., Pfeiffer, R. M., Park, H., Dickensheets, H., Hergott, D., Porter-Gill, P., Mumy, A., Kohaar, I., et al. (2013) · Nature Genetics · doi:10.1038/ng.2521 · Cited by 928
Pan-viral specificity of IFN-induced genes reveals new roles for cGAS in innate immunity
Schoggins, J. W., MacDuff, D. A., Imanaka, N., Gainey, M. D., Shrestha, B., Eitson, J. L., Mar, K. B., Richardson, R. B., Ratushny, A. V., Litvak, V., et al. (2014) · Nature · doi:10.1038/nature12862 · Cited by 896
Self-citationKrug, A., Rothenfusser, S., Hornung, V., Jahrsdörfer, B., Blackwell, S., Ballas, Z. K., Endres, S., Krieg, A. M., & Hartmann, G. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(200107)31:7<2154::aid-immu2154>3.0.co;2-u · Cited by 882
Gack, M. U., Albrecht, R. A., Urano, T., Inn, K.-S., Huang, I.-C., Carnero, E., Farzan, M., Inoue, S., Jung, J. U., & García-Sastre, A. (2009) · Cell Host & Microbe · doi:10.1016/j.chom.2009.04.006 · Cited by 876
Goubau, D., Deddouche, S., & Reis e Sousa, C. (2013) · Immunity · doi:10.1016/j.immuni.2013.05.007 · Cited by 843
Li, X.-D., Sun, L., Seth, R. B., Pineda, G., & Chen, Z. J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508531102 · Cited by 840
Levy, D. E., & Lee, C. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15650 · Cited by 810
Sommereyns, C., Paul, S., Staeheli, P., & Michiels, T. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.1000017 · Cited by 772
Levy, D. E., & Lee, C.-K. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215650 · Cited by 734
LGP2 is a positive regulator of RIG-I– and MDA5-mediated antiviral responses
Satoh, T., Kato, H., Kumagai, Y., Yoneyama, M., Sato, S., Matsushita, K., Tsujimura, T., Fujita, T., Akira, S., & Takeuchi, O. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0912986107 · Cited by 702
Antiviral immunity via RIG-I-mediated recognition of RNA bearing 5'-diphosphates
Goubau, D., Schlee, M., Deddouche, S., Pruijssers, A. J., Zillinger, T., Goldeck, M., Schuberth, C., Van der Veen, A. G., Fujimura, T., Rehwinkel, J., et al. (2014) · Nature · doi:10.1038/nature13590 · Cited by 557 · cited 2×
“[78] identified in addition 5′-diphosphates of RNA molecules that also activate RIG-I.”
BackgroundRonco, L. V., Karpova, A. Y., Vidal, M., & Howley, P. M. (1998) · Genes & Development · doi:10.1101/gad.12.13.2061 · Cited by 544
Sarikas, A., Hartmann, T., & Pan, Z.-Q. (2011) · Genome Biology · doi:10.1186/gb-2011-12-4-220 · Cited by 522
Boulé, M. W., Broughton, C., Mackay, F., Akira, S., Marshak-Rothstein, A., & Rifkin, I. R. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031942 · Cited by 518
Toll-like receptor 9 controls anti-DNA autoantibody production in murine lupus
Christensen, S. R., Kashgarian, M., Alexopoulou, L., Flavell, R. A., Akira, S., & Shlomchik, M. J. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050338 · Cited by 516
Coccia, E. M., Severa, M., Giacomini, E., Monneron, D., Remoli, M. E., Julkunen, I., Cella, M., Lande, R., & Uzé, G. (2004) · European Journal of Immunology · doi:10.1002/eji.200324610 · Cited by 490
Ebola Virus VP24 Binds Karyopherin α1 and Blocks STAT1 Nuclear Accumulation
Reid, S. P., Leung, L. W., Hartman, A. L., Martinez, O., Shaw, M. L., Carbonnelle, C., Volchkov, V. E., Nichol, S. T., & Basler, C. F. (2006) · Journal of Virology · doi:10.1128/jvi.02349-05 · Cited by 463
NS5 of Dengue Virus Mediates STAT2 Binding and Degradation
Ashour, J., Laurent-Rolle, M., Shi, P.-Y., & García-Sastre, A. (2009) · Journal of Virology · doi:10.1128/jvi.02188-08 · Cited by 451
Davis, B. S., Chang, G.-J. J., Cropp, B., Roehrig, J. T., Martin, D. A., Mitchell, C. J., Bowen, R., & Bunning, M. L. (2001) · Journal of Virology · doi:10.1128/jvi.75.9.4040-4047.2001 · Cited by 447
Conlon, J., Burdette, D. L., Sharma, S., Bhat, N., Thompson, M., Jiang, Z., Rathinam, V. A. K., Monks, B., Jin, T., Xiao, T. S., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1300097 · Cited by 434
UBP43 is a novel regulator of interferon signaling independent of its ISG15 isopeptidase activity
Malakhova, O. A., Kim, K., Luo, J., Zou, W., Kumar, K. S., Fuchs, S. Y., Shuai, K., & Zhang, D. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601149 · Cited by 431
Didcock, L., Young, D. F., Goodbourn, S., & Randall, R. E. (1999) · Journal of Virology · doi:10.1128/jvi.73.12.9928-9933.1999 · Cited by 422
IFN-λ determines the intestinal epithelial antiviral host defense
Pott, J., Mahlakõiv, T., Mordstein, M., Duerr, C. U., Michiels, T., Stockinger, S., Staeheli, P., & Hornef, M. W. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1100552108 · Cited by 416
Neipel, F., Albrecht, J. C., & Fleckenstein, B. (1997) · Journal of Virology · doi:10.1128/jvi.71.6.4187-4192.1997 · Cited by 402
Barnes, B. J., Moore, P. A., & Pitha, P. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101216200 · Cited by 388
Goh, K. C. (1999) · The EMBO Journal · doi:10.1093/emboj/18.20.5601 · Cited by 379
Pathogenic potential of interferon αβ in acute influenza infection
Davidson, S., Crotta, S., McCabe, T. M., & Wack, A. (2014) · Nature Communications · doi:10.1038/ncomms4864 · Cited by 369
The host type I interferon response to viral and bacterial infections
PERRY, A. K., CHEN, G., ZHENG, D., TANG, H., & CHENG, G. (2005) · Cell Research · doi:10.1038/sj.cr.7290309 · Cited by 360
Structural Linkage between Ligand Discrimination and Receptor Activation by Type I Interferons
Thomas, C., Moraga, I., Levin, D., Krutzik, P. O., Podoplelova, Y., Trejo, A., Lee, C., Yarden, G., Vleck, S. E., Glenn, J. S., et al. (2011) · Cell · doi:10.1016/j.cell.2011.06.048 · Cited by 356
Oshiumi, H., Matsumoto, M., Hatakeyama, S., & Seya, T. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m804259200 · Cited by 353
Izaguirre, A., Barnes, B. J., Amrute, S., Yeow, W.-S., Megjugorac, N., Dai, J., Feng, D., Chung, E., Pitha, P. M., & Fitzgerald-Bocarsly, P. (2003) · Journal of Leukocyte Biology · doi:10.1189/jlb.0603255 · Cited by 347
Multiple Functions of the IKK-Related Kinase IKKε in Interferon-Mediated Antiviral Immunity
tenOever, B. R., Ng, S.-L., Chua, M. A., McWhirter, S. M., García-Sastre, A., & Maniatis, T. (2007) · Science · doi:10.1126/science.1136567 · Cited by 342
IFNβ-dependent increases in STAT1, STAT2, and IRF9 mediate resistance to viruses and DNA damage
Cheon, H., Holvey-Bates, E. G., Schoggins, J. W., Forster, S., Hertzog, P., Imanaka, N., Rice, C. M., Jackson, M. W., Junk, D. J., & Stark, G. R. (2013) · The EMBO Journal · doi:10.1038/emboj.2013.203 · Cited by 334
Self-citationDisruption of innate immunity due to mitochondrial targeting of a picornaviral protease precursor
Yang, Y., Liang, Y., Qu, L., Chen, Z., Yi, M., Li, K., & Lemon, S. M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611506104 · Cited by 320
Haspel, R. L., Salditt‐Georgieff, M., & Darnell, J. E. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb01016.x · Cited by 312
Rodriguez, J. J., Parisien, J.-P., & Horvath, C. M. (2002) · Journal of Virology · doi:10.1128/jvi.76.22.11476-11483.2002 · Cited by 306
Rajsbaum, R., Albrecht, R. A., Wang, M. K., Maharaj, N. P., Versteeg, G. A., Nistal-Villán, E., García-Sastre, A., & Gack, M. U. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1003059 · Cited by 305
Role of STAT3 in Type I Interferon Responses
Ho, H. H., & Ivashkiv, L. B. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m511797200 · Cited by 302
mda-5, but not RIG-I, is a common target for paramyxovirus V proteins
Childs, K., Stock, N., Ross, C., Andrejeva, J., Hilton, L., Skinner, M., Randall, R., & Goodbourn, S. (2007) · Virology · doi:10.1016/j.virol.2006.09.023 · Cited by 301
Au, W.-C., Moore, P. A., LaFleur, D. W., Tombal, B., & Pitha, P. M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.44.29210 · Cited by 300
Intra-articularly localized bacterial DNA containing CpG motifs induces arthritis
Deng, G.-M., Nilsson, I.-M., Verdrengh, M., Collins, L. V., & Tarkowski, A. (1999) · Nature Medicine · doi:10.1038/9554 · Cited by 297
McWhirter, S. M., Barbalat, R., Monroe, K. M., Fontana, M. F., Hyodo, M., Joncker, N. T., Ishii, K. J., Akira, S., Colonna, M., Chen, Z. J., et al. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20082874 · Cited by 296
Interferon-κ, a Novel Type I Interferon Expressed in Human Keratinocytes
LaFleur, D. W., Nardelli, B., Tsareva, T., Mather, D., Feng, P., Semenuk, M., Taylor, K., Buergin, M., Chinchilla, D., Roshke, V., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102502200 · Cited by 288
STAT Protein Interference and Suppression of Cytokine Signal Transduction by Measles Virus V Protein
Palosaari, H., Parisien, J.-P., Rodriguez, J. J., Ulane, C. M., & Horvath, C. M. (2003) · Journal of Virology · doi:10.1128/jvi.77.13.7635-7644.2003 · Cited by 285
Caskey, M., Lefebvre, F., Filali-Mouhim, A., Cameron, M. J., Goulet, J.-P., Haddad, E. K., Breton, G., Trumpfheller, C., Pollak, S., Shimeliovich, I., et al. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20111171 · Cited by 271
François-Newton, V., Magno de Freitas Almeida, G., Payelle-Brogard, B., Monneron, D., Pichard-Garcia, L., Piehler, J., Pellegrini, S., & Uzé, G. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022200 · Cited by 269
Juang, Y.-T., Lowther, W., Kellum, M., Au, W.-C., Lin, R., Hiscott, J., & Pitha, P. M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.17.9837 · Cited by 266
Oshiumi, H., Miyashita, M., Inoue, N., Okabe, M., Matsumoto, M., & Seya, T. (2010) · Cell Host & Microbe · doi:10.1016/j.chom.2010.11.008 · Cited by 266
Structural basis of a unique interferon-β signaling axis mediated via the receptor IFNAR1
de Weerd, N. A., Vivian, J. P., Nguyen, T. K., Mangan, N. E., Gould, J. A., Braniff, S.-J., Zaker-Tabrizi, L., Fung, K. Y., Forster, S. C., Beddoe, T., et al. (2013) · Nature Immunology · doi:10.1038/ni.2667 · Cited by 264
Interferon-ε Protects the Female Reproductive Tract from Viral and Bacterial Infection
Fung, K. Y., Mangan, N. E., Cumming, H., Horvat, J. C., Mayall, J. R., Stifter, S. A., De Weerd, N., Roisman, L. C., Rossjohn, J., Robertson, S. A., et al. (2013) · Science · doi:10.1126/science.1233321 · Cited by 261
Shaw, M. L., García-Sastre, A., Palese, P., & Basler, C. F. (2004) · Journal of Virology · doi:10.1128/jvi.78.11.5633-5641.2004 · Cited by 256
Reid, S. P., Valmas, C., Martinez, O., Sanchez, F. M., & Basler, C. F. (2007) · Journal of Virology · doi:10.1128/jvi.01097-07 · Cited by 248
Cytoplasmic DNA innate immune pathways
Barber, G. N. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01051.x · Cited by 245
Li, S., Labrecque, S., Gauzzi, M. C., Cuddihy, A. R., Wong, A. H., Pellegrini, S., Matlashewski, G. J., & Koromilas, A. E. (1999) · Oncogene · doi:10.1038/sj.onc.1202960 · Cited by 245
Wei, C., Ni, C., Song, T., Liu, Y., Yang, X., Zheng, Z., Jia, Y., Yuan, Y., Guan, K., Xu, Y., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903874 · Cited by 235
Stat Protein Transactivation Domains Recruit p300/CBP through Widely Divergent Sequences
Paulson, M., Pisharody, S., Pan, L., Levy, D. E., Guadagno, S., & Mui, A. L. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.36.25343 · Cited by 234
Piehler, J., Thomas, C., Garcia, K. C., & Schreiber, G. (2012) · Immunological Reviews · doi:10.1111/imr.12001 · Cited by 230
Mazzon, M., Jones, M., Davidson, A., Chain, B., & Jacobs, M. (2009) · The Journal of Infectious Diseases · doi:10.1086/605847 · Cited by 230
The Human Papillomavirus E7 Oncoprotein Abrogates Signaling Mediated by Interferon-α
Barnard, P., & McMillan, N. A. J. (1999) · Virology · doi:10.1006/viro.1999.9771 · Cited by 227
Jaitin, D. A., Roisman, L. C., Jaks, E., Gavutis, M., Piehler, J., Van der Heyden, J., Uze, G., & Schreiber, G. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.5.1888-1897.2006 · Cited by 225
Differential Receptor Subunit Affinities of Type I Interferons Govern Differential Signal Activation
Jaks, E., Gavutis, M., Uzé, G., Martal, J., & Piehler, J. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2006.11.053 · Cited by 223
Patole, P. S., Gro[Combining Diaeresis]ne, H.-J., Segerer, S., Ciubar, R., Belemezova, E., Henger, A., Kretzler, M., Schlo[Combining Diaeresis]ndorff, D., & Anders, H.-J. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004100820 · Cited by 222
Parisien, J.-P., Lau, J. F., Rodriguez, J. J., Sullivan, B. M., Moscona, A., Parks, G. D., Lamb, R. A., & Horvath, C. M. (2001) · Virology · doi:10.1006/viro.2001.0856 · Cited by 220
Recognition of nucleic acids by pattern‐recognition receptors and its relevance in autoimmunity
Kawasaki, T., Kawai, T., & Akira, S. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01048.x · Cited by 217
A Virological View of Innate Immune Recognition
Iwasaki, A. (2012) · Annual Review of Microbiology · doi:10.1146/annurev-micro-092611-150203 · Cited by 217
Prantner, D., Perkins, D. J., Lai, W., Williams, M. S., Sharma, S., Fitzgerald, K. A., & Vogel, S. N. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.382986 · Cited by 216
Burýšek, L., Yeow, W.-S., Lubyová, B., Kellum, M., Schafer, S. L., Huang, Y. Q., & Pitha, P. M. (1999) · Journal of Virology · doi:10.1128/jvi.73.9.7334-7342.1999 · Cited by 214
Lin, R., Genin, P., Mamane, Y., Sgarbanti, M., Battistini, A., Harrington, W. J., Barber, G. N., & Hiscott, J. (2001) · Oncogene · doi:10.1038/sj.onc.1204163 · Cited by 212
Acetylation-Dependent Signal Transduction for Type I Interferon Receptor
Tang, X., Gao, J.-S., Guan, Y.-J., McLane, K. E., Yuan, Z.-L., Ramratnam, B., & Chin, Y. E. (2007) · Cell · doi:10.1016/j.cell.2007.07.034 · Cited by 211
Shaw, M. L., Cardenas, W. B., Zamarin, D., Palese, P., & Basler, C. F. (2005) · Journal of Virology · doi:10.1128/jvi.79.10.6078-6088.2005 · Cited by 209
Role of the Akt pathway in mRNA translation of interferon-stimulated genes
Kaur, S., Sassano, A., Dolniak, B., Joshi, S., Majchrzak-Kita, B., Baker, D. P., Hay, N., Fish, E. N., & Platanias, L. C. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0710907105 · Cited by 206
Uddin, S., Yenush, L., Sun, X.-J., Sweet, M. E., White, M. F., & Platanias, L. C. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.27.15938 · Cited by 199
Stahl-Hennig, C., Eisenblätter, M., Jasny, E., Rzehak, T., Tenner-Racz, K., Trumpfheller, C., Salazar, A. M., Überla, K., Nieto, K., Kleinschmidt, J., et al. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000373 · Cited by 198
Herpes Simplex Virus 1 Has Multiple Mechanisms for Blocking Virus-Induced Interferon Production
Melroe, G. T., DeLuca, N. A., & Knipe, D. M. (2004) · Journal of Virology · doi:10.1128/jvi.78.16.8411-8420.2004 · Cited by 197
Abate, D. A., Watanabe, S., & Mocarski, E. S. (2004) · Journal of Virology · doi:10.1128/jvi.78.20.10995-11006.2004 · Cited by 197
Larner, A. C., Chaudhuri, A., & Darnell, J. E. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42492-6 · Cited by 196
Dynamic control of type I IFN signalling by an integrated network of negative regulators
Porritt, R. A., & Hertzog, P. J. (2015) · Trends in Immunology · doi:10.1016/j.it.2015.02.002 · Cited by 196
The molecular basis for functional plasticity in type I interferon signaling
Schreiber, G., & Piehler, J. (2015) · Trends in Immunology · doi:10.1016/j.it.2015.01.002 · Cited by 193
STAT3 Ubiquitylation and Degradation by Mumps Virus Suppress Cytokine and Oncogene Signaling
Ulane, C. M., Rodriguez, J. J., Parisien, J.-P., & Horvath, C. M. (2003) · Journal of Virology · doi:10.1128/jvi.77.11.6385-6393.2003 · Cited by 193
Takeuchi, K., Kadota, S.-I., Takeda, M., Miyajima, N., & Nagata, K. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)00528-3 · Cited by 191
Mouse STAT2 Restricts Early Dengue Virus Replication
Ashour, J., Morrison, J., Laurent-Rolle, M., Belicha-Villanueva, A., Plumlee, C. R., Bernal-Rubio, D., Williams, K. L., Harris, E., Fernandez-Sesma, A., Schindler, C., et al. (2010) · Cell Host & Microbe · doi:10.1016/j.chom.2010.10.007 · Cited by 189
Binding and activity of all human alpha interferon subtypes
Lavoie, T. B., Kalie, E., Crisafulli-Cabatu, S., Abramovich, R., DiGioia, G., Moolchan, K., Pestka, S., & Schreiber, G. (2011) · Cytokine · doi:10.1016/j.cyto.2011.07.019 · Cited by 182
Constitutive and IFN-γ-induced nuclear import of STAT1 proceed through independent pathways
Meyer, T., Begitt, A., Lödige, I., van Rossum, M., & Vinkemeier, U. (2002) · The EMBO Journal · doi:10.1093/emboj/21.3.344 · Cited by 181
Marburg Virus Evades Interferon Responses by a Mechanism Distinct from Ebola Virus
Valmas, C., Grosch, M. N., Schümann, M., Olejnik, J., Martinez, O., Best, S. M., Krähling, V., Basler, C. F., & Mühlberger, E. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000721 · Cited by 180
Evolutionary genetic dissection of human interferons
Manry, J., Laval, G., Patin, E., Fornarino, S., Itan, Y., Fumagalli, M., Sironi, M., Tichit, M., Bouchier, C., Casanova, J.-L., et al. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20111680 · Cited by 176
IFN‐α subtypes: distinct biological activities in anti‐viral therapy
Gibbert, K., Schlaak, J., Yang, D., & Dittmer, U. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12010 · Cited by 174
Ligand-Induced Association of the Type I Interferon Receptor Components
Cohen, B., Novick, D., Barak, S., & Rubinstein, M. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.8.4208 · Cited by 174
[4] Production of interferon in human leukocytes from normal donors with the use of Sendai virus
Cantell, K., Hirvonen, S., Kauppinen, H.-L., & Myllylä, G. (1981) · Methods in Enzymology · doi:10.1016/0076-6879(81)78094-7 · Cited by 173
The chemotherapeutic agent DMXAA potently and specifically activates the TBK1–IRF-3 signaling axis
Roberts, Z. J., Goutagny, N., Perera, P.-Y., Kato, H., Kumar, H., Kawai, T., Akira, S., Savan, R., van Echo, D., Fitzgerald, K. A., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20061845 · Cited by 169
Human blood mDC subsets exhibit distinct TLR repertoire and responsiveness
Hémont, C., Neel, A., Heslan, M., Braudeau, C., & Josien, R. (2013) · Journal of Leukocyte Biology · doi:10.1189/jlb.0912452 · Cited by 167
Direct Suppression of Stat1 Function during Adenoviral Infection
Look, D. C., Roswit, W. T., Frick, A. G., Gris-Alevy, Y., Dickhaus, D. M., Walter, M. J., & Holtzman, M. J. (1998) · Immunity · doi:10.1016/s1074-7613(00)80652-4 · Cited by 165
Rodriguez, J. J., Wang, L.-F., & Horvath, C. M. (2003) · Journal of Virology · doi:10.1128/jvi.77.21.11842-11845.2003 · Cited by 164
Structure−Activity Relationships in Human Toll-Like Receptor 7-Active Imidazoquinoline Analogues
Shukla, N. M., Malladi, S. S., Mutz, C. A., Balakrishna, R., & David, S. A. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100358c · Cited by 163
Egli, A., Santer, D. M., O’Shea, D., Tyrrell, D. L., & Houghton, M. (2014) · Emerging Microbes & Infections · doi:10.1038/emi.2014.51 · Cited by 160
PIAS proteins promote SUMO-1 conjugation to STAT1
Ungureanu, D., Vanhatupa, S., Kotaja, N., Yang, J., Aittomäki, S., Jänne, O. A., Palvimo, J. J., & Silvennoinen, O. (2003) · Blood · doi:10.1182/blood-2002-12-3816 · Cited by 158
A stuttering model for paramyxovirus P mRNA editing.
Vidal, S., Curran, J. A., & Kolakofsky, D. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb08330.x · Cited by 156
Thomas, K. E., Galligan, C. L., Newman, R. D., Fish, E. N., & Vogel, S. N. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m604958200 · Cited by 153
Rodriguez, J. J., Cruz, C. D., & Horvath, C. M. (2004) · Journal of Virology · doi:10.1128/jvi.78.10.5358-5367.2004 · Cited by 146
Perry, S. T., Buck, M. D., Lada, S. M., Schindler, C., & Shresta, S. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1001297 · Cited by 144
Childs, K., Randall, R. E., & Goodbourn, S. (2012) · Journal of Virology · doi:10.1128/jvi.06405-11 · Cited by 143
Measles virus V protein blocks Jak1-mediated phosphorylation of STAT1 to escape IFN-α/β signaling
Caignard, G., Guerbois, M., Labernardière, J., Jacob, Y., Jones, L. M., Wild, F. T., Tangy, F., & Vidalain, P. (2007) · Virology · doi:10.1016/j.virol.2007.06.037 · Cited by 141
Chenik, M., Chébli, K., & Blondel, D. (1995) · Journal of Virology · doi:10.1128/jvi.69.2.707-712.1995 · Cited by 140
Epstein-Barr Virus BGLF4 Kinase Suppresses the Interferon Regulatory Factor 3 Signaling Pathway
Wang, J.-T., Doong, S.-L., Teng, S., Lee, C., Tsai, C.-H. A., & Chen, M. (2008) · Journal of Virology · doi:10.1128/jvi.01099-08 · Cited by 140
Bis-(3′,5′)-cyclic dimeric adenosine monophosphate: Strong Th1/Th2/Th17 promoting mucosal adjuvant
Ebensen, T., Libanova, R., Schulze, K., Yevsa, T., Morr, M., & Guzmán, C. A. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.05.026 · Cited by 137
The V Protein of the Paramyxovirus SV5 Interacts with Damage-Specific DNA Binding Protein
Lin, G., Paterson, R. G., Richardson, C. D., & Lamb, R. A. (1998) · Virology · doi:10.1006/viro.1998.9317 · Cited by 137
Mechanism of mda-5 Inhibition by Paramyxovirus V Proteins
Childs, K., Andrejeva, J., Randall, R. E., & Goodbourn, S. (2008) · Journal of Virology · doi:10.1128/jvi.01768-08 · Cited by 134
A Shared Interface Mediates Paramyxovirus Interference with Antiviral RNA Helicases MDA5 and LGP2
Parisien, J.-P., Bamming, D., Komuro, A., Ramachandran, A., Rodriguez, J. J., Barber, G. N., Wojahn, R. D., & Horvath, C. M. (2009) · Journal of Virology · doi:10.1128/jvi.00153-09 · Cited by 132
Leung‐Pineda, V., Huh, J., & Piwnica-Worms, H. M. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3382 · Cited by 131
Marchetti, M., Monier, M., Fradagrada, A., Mitchell, K., Baychelier, F., Eid, P., Johannes, L., & Lamaze, C. (2006) · Molecular Biology of the Cell · doi:10.1091/mbc.e06-01-0076 · Cited by 129
Hong, S., Mehta, K. P. M., & Laimins, L. A. (2011) · Journal of Virology · doi:10.1128/jvi.05007-11 · Cited by 122
Dalpke, A. H., Zimmermann, S., Albrecht, I., & Heeg, K. M. (2002) · Immunology · doi:10.1046/j.1365-2567.2002.01410.x · Cited by 120
Multifaceted Activities of Type I Interferon Are Revealed by a Receptor Antagonist
Levin, D., Schneider, W. M., Hoffmann, H.-H., Yarden, G., Busetto, A. G., Manor, O., Sharma, N., Rice, C. M., & Schreiber, G. (2014) · Science Signaling · doi:10.1126/scisignal.2004998 · Cited by 111
Self-citationHillyer, P., Mane, V. P., Schramm, L. M., Puig, M., Verthelyi, D. I., Chen, A., Zhao, Z., Navarro, M. B., Kirschman, K. D., Bykadi, S., et al. (2012) · Immunology and Cell Biology · doi:10.1038/icb.2011.109 · Cited by 110
Parisien, J.-P., Lau, J. F., & Horvath, C. M. (2002) · Journal of Virology · doi:10.1128/jvi.76.13.6435-6441.2002 · Cited by 106
Andrejeva, J., Poole, E. L., Young, D. F., Goodbourn, S., & Randall, R. E. (2002) · Journal of Virology · doi:10.1128/jvi.76.22.11379-11386.2002 · Cited by 106
Receptor Density Is Key to the Alpha2/Beta Interferon Differential Activities
Moraga, I., Harari, D., Schreiber, G., Uzé, G., & Pellegrini, S. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.01808-08 · Cited by 105
Stochastic Receptor Expression Determines Cell Fate upon Interferon Treatment
Levin, D., Harari, D., & Schreiber, G. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.05251-11 · Cited by 105
Gotoh, B., Takeuchi, K., Komatsu, T., & Yokoo, J. (2003) · Journal of Virology · doi:10.1128/jvi.77.6.3360-3370.2003 · Cited by 102
Zipris, D., Lien, E., Nair, A., Xie, J. X., Greiner, D. L., Mordes, J. P., & Rossini, A. A. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.2.693 · Cited by 99
Makowska, Z., Duong, F. H. T., Trincucci, G., Tough, D. F., & Heim, M. H. (2011) · Hepatology · doi:10.1002/hep.24189 · Cited by 99
Lu, L. L., Puri, M., Horvath, C. M., & Sen, G. C. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m710089200 · Cited by 96
Regulation of Interferon-α Responsiveness by the Duration of Janus Kinase Activity
Lee, C.-K., Bluyssen, H. A. R., & Levy, D. E. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.35.21872 · Cited by 87
Génin, P., Lin, R., Hiscott, J. B., & Civas, A. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.01805-08 · Cited by 85
Moll, H. P., Maier, T. H. P., Zommer, A., Lavoie, T., & Brostjan, C. (2010) · Cytokine · doi:10.1016/j.cyto.2010.09.006 · Cited by 84
Marburg Virus VP40 Antagonizes Interferon Signaling in a Species-Specific Manner
Valmas, C., & Basler, C. F. (2011) · Journal of Virology · doi:10.1128/jvi.02575-10 · Cited by 83
Transcription mapping of human herpesvirus 8 genes encoding viral interferon regulatory factors
Cunningham, C., Barnard, S., Blackbourn, D. J., & Davison, A. J. (2003) · Journal of General Virology · doi:10.1099/vir.0.19015-0 · Cited by 77
Measles Virus C Protein Interferes with Beta Interferon Transcription in the Nucleus
Sparrer, K. M. J., Pfaller, C. K., & Conzelmann, K. (2011) · Journal of Virology · doi:10.1128/jvi.05899-11 · Cited by 76
Yokosawa, N., Yokota, S., Kubota, T., et al. (2002) · Journal of Virology · doi:10.1128/jvi.76.24.12683-12690.2002 · Cited by 75
Fidock, M. D., Souberbielle, B. E., Laxton, C. D., Rawal, J. K., Delpuech-Adams, O. E., Corey, T., Colman, P., Kumar, V., Cheng, J. B., Wright, K., et al. (2011) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2011.60 · Cited by 71
Cooper, C., & Mackie, D. (2011) · Expert Review of Vaccines · doi:10.1586/erv.10.162 · Cited by 69
Sendai virus C protein impairs both phosphorylation and dephosphorylation processes of Stat1
Komatsu, T., Takeuchi, K., Yokoo, J., & Gotoh, B. (2002) · FEBS Letters · doi:10.1016/s0014-5793(01)03301-4 · Cited by 68
Innate immune recognition of nucleic acids: Beyond toll-like receptors
Ishii, K. J., & Akira, S. (2005) · International Journal of Cancer · doi:10.1002/ijc.21402 · Cited by 67
Geiger, T. R., & Martin, J. (2006) · Journal of Virology · doi:10.1128/jvi.01570-06 · Cited by 67
Cloutier, N., & Flamand, L. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.018838 · Cited by 64
Role of novel type I interferon epsilon in viral infection and mucosal immunity
Xi, Y., Day, S., Jackson, R. J., & Ranasinghe, C. (2012) · Mucosal Immunology · doi:10.1038/mi.2012.35 · Cited by 63
Interferon-alpha Subtype 11 Activates NK Cells and Enables Control of Retroviral Infection
Sutter, K., Joedicke, J. J., Meryk, A., Trilling, M., Francois, S., Duppach, J., Kraft, A. R. M., Lang, K. S., & Dittmer, U. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002868 · Cited by 59
Inhibition of Interferon Regulatory Factor 3 Activation by Paramyxovirus V Protein
Irie, T., Kiyotani, K., Igarashi, T., et al. (2012) · Journal of Virology · doi:10.1128/jvi.06705-11 · Cited by 58
Garcin, D., Marq, J., Goodbourn, S., & Kolakofsky, D. (2003) · Journal of Virology · doi:10.1128/jvi.77.4.2321-2329.2003 · Cited by 57
3′,5′-Cyclic diguanylic acid elicits mucosal immunity against bacterial infection
Yan, H., KuoLee, R., Tram, K., et al. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.07.061 · Cited by 53
Puig, M., Tosh, K. W., Schramm, L. M., Grajkowska, L. T., Kirschman, K. D., Tami, C., Beren, J. J., Rabin, R. L., & Verthelyi, D. I. (2011) · Journal of Leukocyte Biology · doi:10.1189/jlb.0711371 · Cited by 45
Frenz, T., Graalmann, L., Detje, C. N., Döring, M., Grabski, E., Scheu, S., & Kalinke, U. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400215 · Cited by 44
Saito, S., Ogino, T., Miyajima, N., Kato, A., & Kohase, M. (2002) · Virology · doi:10.1006/viro.2001.1250 · Cited by 38
Thomas, J. M., Pós, Z., Reinboth, J., Wang, R. Y., Wang, E., Frank, G. M., Lusso, P., Trinchieri, G., Alter, H. J., Marincola, F. M., et al. (2014) · Journal of Virology · doi:10.1128/jvi.01501-14 · Cited by 34
Baig, E., & Fish, E. N. (2008) · Antiviral Therapy · doi:10.1177/135965350801300306 · Cited by 33
Rigid Interferon-α Subtype Responses of Human Plasmacytoid Dendritic Cells
Szubin, R., Chang, W. L. W., Greasby, T. A., Beckett, L. A., & Baumgarth, N. (2008) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2008.0037 · Cited by 30
The Early Interferon Alpha Subtype Response in Infant Macaques Infected Orally With SIV
Easlick, J. L., Szubin, R., Lantz, S. M., Baumgarth, N., & Abel, K. (2010) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e3181e696ca · Cited by 25
Wijesundara, D. K., Xi, Y., & Ranasinghe, C. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00412 · Cited by 22
Biochemical Monitoring of the Early Endocytic Traffic of the Type I Interferon Receptor
Payelle‐Brogard, B., & Pellegrini, S. (2009) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2009.0044 · Cited by 19
Cited by
Autoantibodies against type I IFNs in patients with life-threatening COVID-19
Bastard, P., Rosen, L. B., Zhang, Q., Michailidis, E., Hoffmann, H.-H., Zhang, Y., Dorgham, K., Philippot, Q., Rosain, J., Béziat, V., et al. (2020) · Science · doi:10.1126/science.abd4585 · Cited by 2,662
Self-citationApproved Antiviral Drugs over the Past 50 Years
De Clercq, E., & Li, G. (2016) · Clinical Microbiology Reviews · doi:10.1128/cmr.00102-15 · Cited by 1,430
Shared and Distinct Functions of Type I and Type III Interferons
Lazear, H. M., Schoggins, J. W., & Diamond, M. S. (2019) · Immunity · doi:10.1016/j.immuni.2019.03.025 · Cited by 1,138
SARS-CoV-2 Orf6 hijacks Nup98 to block STAT nuclear import and antagonize interferon signaling
Miorin, L., Kehrer, T., Sanchez-Aparicio, M. T., Zhang, K., Cohen, P., Patel, R. S., Cupic, A., Makio, T., Mei, M., Moreno, E., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2016650117 · Cited by 527
Interferon-λ: Immune Functions at Barrier Surfaces and Beyond
Lazear, H. M., Nice, T. J., & Diamond, M. S. (2015) · Immunity · doi:10.1016/j.immuni.2015.07.001 · Cited by 480
Metadata
- Authors
- Hoffmann, H.-H., Schneider, W. M., & Rice, C. M.
- Venue
- Trends in Immunology
- Publisher
- Elsevier BV
- Published
- 2015-03
- Volume
- 36
- Issue
- 3
- Pages
- 124-138
- ISSN
- 1471-4906 (ISSN-L)
- OpenAlex
- W1978525119
- Cited by
- 410
- References
- 180
- FWCI
- 2.80
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.